Fairvoy Private Wealth LLC Sells 5,019 Shares of Doximity, Inc. (NASDAQ:DOCS)

Fairvoy Private Wealth LLC reduced its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 26.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,611 shares of the company's stock after selling 5,019 shares during the period. Fairvoy Private Wealth LLC's holdings in Doximity were worth $790,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of DOCS. Global Retirement Partners LLC increased its position in shares of Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after purchasing an additional 440 shares in the last quarter. Larson Financial Group LLC boosted its stake in shares of Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after acquiring an additional 250 shares in the last quarter. Optimum Investment Advisors purchased a new stake in Doximity in the 4th quarter valued at approximately $43,000. Kapitalo Investimentos Ltda purchased a new stake in Doximity in the 4th quarter valued at approximately $50,000. Finally, Huntington National Bank raised its holdings in Doximity by 1,440.8% in the 4th quarter. Huntington National Bank now owns 1,094 shares of the company's stock valued at $58,000 after acquiring an additional 1,023 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Needham & Company LLC lowered their price target on Doximity from $82.00 to $67.00 and set a "buy" rating for the company in a report on Friday, May 16th. William Blair restated an "outperform" rating on shares of Doximity in a research report on Friday, May 16th. Raymond James lowered their price target on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. JPMorgan Chase & Co. cut their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research report on Tuesday, May 27th. Finally, Canaccord Genuity Group decreased their price objective on shares of Doximity from $71.00 to $50.00 and set a "hold" rating on the stock in a research note on Friday, May 16th. Eleven research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $62.84.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the completion of the transaction, the director now directly owns 16,618 shares of the company's stock, valued at $946,062.74. This represents a 10.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the transaction, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at approximately $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,000 shares of company stock valued at $2,900,770. 37.40% of the stock is owned by insiders.

Doximity Stock Down 1.8%

Shares of DOCS stock traded down $1.04 during trading hours on Friday, hitting $55.92. 1,284,854 shares of the company's stock were exchanged, compared to its average volume of 2,141,090. The firm has a market cap of $10.50 billion, a P/E ratio of 55.92, a P/E/G ratio of 4.10 and a beta of 1.32. The firm has a 50 day moving average of $55.13 and a two-hundred day moving average of $58.46. Doximity, Inc. has a fifty-two week low of $25.00 and a fifty-two week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same quarter last year, the business posted $0.25 EPS. The company's quarterly revenue was up 17.1% compared to the same quarter last year. On average, equities analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.